This newsletter is sponsored by the NLN Garment Program Sponsors: medi USA, Essity JOBST, Juzo USA, & Wear Ease | | | medi® USA is a medical products and technologies company focused on compression therapies for chronic medical conditions, athletic performance and fashion. | | | | | JOBST®, a brand of Essity, provides solutions for the prevention, treatment and management of venous and lymphatic conditions; and offers world-class clinical education, sales and customer service support for healthcare professionals, business partners and patients. | | | | | Family-owned since 1912, Juzo manufactures a variety of compression therapy garments designed specifically to offer people affected by venous and lymphatic conditions the freedom to keep moving and maintain an active lifestyle. | | | | | Wear Ease therapeutic compression shapewear is designed to provide compression high under the arm and high on the back. Our goal is to provide attractive and comfortable products that ensure 100% compliance because you want to wear them! | | | | |
Virtual Part II of A Mysterious Experience of Lymphology Complimentary to all our valued NLN Members!
The conference dates are 3/12/22, 3/13/22, and 3/19/22. Members, keep an eye out for the registration email.
Thank you so much for your support!
| | | | | NLN Virtual Exhibit Hall is Open to Our Entire Lymphedema Community | This is an amazing opportunity to learn about the latest and greatest from lymphedema industry leaders. Support those that support the NLN and join our meetings.
Scan the QR Code to the left or click the link below to register for free for the NLN Virtual Exhibit Hall on
Sat 3/12/22 from 2:30-4:00 pm ET | | | | | Giveaways Galore!
We have 3 days you can join so that you can receive free product samples, free compression garments, and free NLN Membership.
Scan the QR Code to the left or click the link below to register for free for the NLN Virtual Exhibit Hall on
Sun 3/13/22 from 2:30-4:00 pm ET | | | | | Scan the QR Code to the left or click the link below to register for free for the NLN Virtual Exhibit Hall on
Sat 3/19/22 from 2:30-4:00 pm ET | New Sponsors Welcome! We invite new sponsors to join the March festivities and connect with our amazing lymphedema community comprised of passionate lymphedema clinicians and patient advocates. | | | | | High Re‐Exploration Rate of Vascularized Lymph Node Transplantations in Primary Lymphedema With Heparin‐Induced Thrombocytopenia and Thrombosis
published Feb 14, 2022 by Hematology Advisor
| | | | | Scaling-up Filariasis Lymphoedema Management into the Primary Health Care System in Kerala State, Southern India: a Case Study in Healthcare Equity
published Jan 18, 2022 by Infectious Diseases of Poverty
| | | | | Bioimpedance Spectroscopy Is a Better Predictor of Chronic Lymphedema Vs Tape Measurement | published Feb 6, 2022 by Oncology Nursing News
| | | | |
Manipulating Lymphatic Growth: Dr. Pengchun Yu | Published Feb 14, 2022 by Yale School of Medicine
| | | | | A First Glimpse of the Human Brain’s Drains | Published Feb 24, 2022 by Medical University of South Carolina
| | | | Disclaimer: Inclusion of advertisements in this newsletter does not constitute the National Lymphedema Network's endorsement, guarantee of quality, or claim of value made by the manufacturer, distributor, owner, or service provider. The National Lymphedema Network aims to simply connect patients and health care professionals to information they may find useful when exploring treatment options, educational opportunities, and current information related to lymphedema and related conditions. The views and opinions in articles included in this newsletter, which are those of the author(s), do not necessarily reflect the official policy or position of the National Lymphedema Network. The information is provided solely for general education and informational purposes. Use of the advice and information contained herein is at your sole choice and risk. You should not rely on this information as a substitute for, nor does it replace, professional medical advice, diagnosis, or treatment. Always consult your physician or healthcare provider before beginning any nutrition or exercise program. If you choose to use this information without prior consent of your physician, you are agreeing to accept full responsibility for your decisions and agreeing to hold harmless the National Lymphedema Network. | | | | | | |
|